×
0.000504032258064595 0.00302419354838721 -0.00100806451612901 0.0110887096774195 0.00957661290322587 0.0181451612903226 0.0262096774193548 0.0423387096774193
Stockreport

GenMark Q2 miss sinks shares, down 16% [Seeking Alpha]

GENMARK DIAGNOSTICS (GNMK)  More Company Research Source: Seeking Alpha
Last genmark diagnostics earnings: 7/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.genmarkdx.com/investor-relations
PDF Thinly traded micro cap GenMark Diagnostics ( GNMK ) slips on almost 50% higher volume after it reported Q2 results that fell short of consensus. Total revenues: $12.4M (-0.8%); product sales: $12.3M (-0.8%); net loss: ($18.0M) (-39.5%); loss/share: ($0.37) (-23.3%); cash flow ops (6 mo.): ($28.2M) (-81.9%). Quick assets totaled $106.5M at the end of June. The company's ePlex instrument and Blood Culture ID Panels were cleared for sale in the U.S. and EU. so investors will be expecting a solid ramp. Previously: GenMark Diagnostics misses by $0.05, misses on revenue (Aug. 1) Now read: Pulse Biosciences: Who Was In That Room? » [Read more]

IMPACT SNAPSHOT EVENT TIME: GNMK
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS